A Qsymia CardiovascuLAr morbIdity and Mortality (AQCLAIM) Study in Subjects with Documented Cardiovascular Disease.

Trial Profile

A Qsymia CardiovascuLAr morbIdity and Mortality (AQCLAIM) Study in Subjects with Documented Cardiovascular Disease.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 28 Oct 2016

At a glance

  • Drugs Phentermine/topiramate (Primary)
  • Indications Cardiovascular disorders; Obesity
  • Focus Therapeutic Use
  • Acronyms AQCLAIM
  • Sponsors PPD; VIVUS
  • Most Recent Events

    • 05 Sep 2014 New source identified and integrated (United Kingdom Clinical Research Network record:15440)
    • 22 Oct 2013 Status changed from planning to recruiting, according to European Clinical Trials Database record.
    • 22 Oct 2013 New source identified and integrated: European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top